Our melanoma nomogram is a prediction tool designed to help patients with primary skin melanoma and their physicians calculate the likelihood that the cancer has metastasized (spread) to the sentinel lymph node (the first lymph node to which cancer cells are likely to spread from the primary tumor). It is appropriate for patients who have not yet had a sentinel lymph node biopsy.

All results should be discussed with a physician and understood in the context of each patient’s program of care. Results from the melanoma nomogram are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of melanoma procedures. This tool was externally validated using data from a large, multi-institutional clinical trial, and was further evaluated and validated by three separate institutions (see Supporting Publications).

Use our Melanoma: Risk of Sentinel Lymph Node Metastasis nomogram.